Home›Companies›Biotech & Pharma›Theravie Pharma

Theravie Pharma, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 8, 2026·Latest SEC filing Oct 19, 2026·Suggest an edit

About Theravie Pharma

Theravie Pharma is a private company based in San Diego, California, incorporated in 2025 in Delaware. It has reported $750,000 raised in one offering on Form D since October 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 29, 2026Oct 19, 2026$750,000of $2.2M target1$750KEquity, Simple Agreement for Future Equity (SAFE), a contractual right to receive equity securities upon the occurrence of specified future financing events.Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Theravie Pharma's Form D filed Oct 19, 2026.

SA
Samia Almoughrabie
President and director
RG
Richard Gallo
Executive officer and director

Sources

  1. SECTheravie Pharma, Inc. filing history